| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/2007 | CN1955298A New use of rice shunt virus non-structure protein Pns10 |
| 05/02/2007 | CN1955191A New gene PPF1 of class I control infection nail forming efficiency and pathogenicity in flamentous etiological fungus and its use |
| 05/02/2007 | CN1955190A Polypeptide of controlling IIIv virus fusion and its use |
| 05/02/2007 | CN1954883A Method for stabilizing hemoglobin oxygen carrier sample |
| 05/02/2007 | CN1313617C Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 05/02/2007 | CN1313611C Novel tumor wilting matter 2 ligand gene, its expressed tumor wilting matter and its preparation method |
| 05/02/2007 | CN1313493C Method of producing human albumin involving heating step |
| 05/02/2007 | CN1313492C B-chain modified monomer quick-acting insulin and method for preparing same |
| 05/02/2007 | CN1313491C Cat omega interferon and its coding gene and uses |
| 05/02/2007 | CN1313490C Segregative technique for purifying stimulating factor of recombined human beta lymphocyte |
| 05/02/2007 | CN1313489C GP thymosin alpha 1 and preparation method |
| 05/02/2007 | CN1313488C Method for retrieving albumin form constituent deposition 123 |
| 05/02/2007 | CN1313487C Immunoreactive peptide Trpi possessing antibacterial action |
| 05/02/2007 | CN1313486C Plant DREB transcription factor and its coding gene and use |
| 05/02/2007 | CN1313485C Method for preparing thermophilic protein by heating and crushing genetic engineering bacterium |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/02/2007 | CN1313149C Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 05/02/2007 | CN1313082C Slow releasing composition and its preparing method |
| 05/01/2007 | US7211717 Plants and seeds of corn variety I285291 |
| 05/01/2007 | US7211716 comprising a nuclear or cytoplasmic gene conferring male sterility, insect resistance; disease resistance; waxy starch; decreased phytate content, modified fatty acid metabolism, modified carbohydrate metabolism |
| 05/01/2007 | US7211713 transgenic plant exhibits tolerance to normally toxic levels of glyphosate; DNA is of EPSP synthase operably linked to an actin promoter; into the genome of said plant or a plant of a previous generation thereof by microprojectile bombardment |
| 05/01/2007 | US7211711 Compositions and methods for the modification of gene expression |
| 05/01/2007 | US7211710 Grapevine fanleaf virus resistance in grapevine |
| 05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/01/2007 | US7211655 Methods for identifying modulators of transcriptional activator protein interactions |
| 05/01/2007 | US7211652 Protein from horn fly saliva that disrupts hemostasis |
| 05/01/2007 | US7211651 Proteinaceous gels having visualization agents and methods of use thereof |
| 05/01/2007 | US7211650 Separation of preferential protein from milk; obtain milk, transfer protease into whey layer, remove and recover protease from whey layer |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211647 DNA synthetase |
| 05/01/2007 | US7211646 Chondrosarcoma associated genes |
| 05/01/2007 | US7211645 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 05/01/2007 | US7211569 Synthetic human papilloma virus genes |
| 05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 05/01/2007 | US7211564 Methods and construction and screening of libraries of chemokine variants |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211560 Hemoglobulin for oxygen delivery; cardiovascular disorders; gastrointestinal disorders |
| 05/01/2007 | US7211559 Mutant factor VIII, substituting amino acidsin the A2 domain increases the circulating half-life and/or specific activity; procoagulant activity |
| 05/01/2007 | US7211558 Comprises nucleotide sequences coding recombinant antihemophilic factor for treatment of blood disorders |
| 05/01/2007 | US7211557 Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 05/01/2007 | US7211435 Telomerase expression repressor proteins and methods of using the same |
| 05/01/2007 | US7211432 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigents), intercellular adhesion molecules and leukocyte function associated antigen-3 |
| 05/01/2007 | US7211431 Expression vector comprising heterologous nucleotide sequences which enhance amino acid biosynthesis in plants; bioreactor; tissue engineering; for use in enhancing nutritional content of animal feeds |
| 05/01/2007 | US7211408 Comprising at least two regions, each region preferably having human T cell stimulating activity and each region comprising at least one T cell epitope derived from a protein antigen |
| 05/01/2007 | US7211406 Potassium channel |
| 05/01/2007 | US7211405 Polypeptide for use in the detection of pregnancy complications |
| 05/01/2007 | US7211402 For selectively inhibiting signal transduction pathways using an active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such an acive fragment |
| 05/01/2007 | US7211400 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 05/01/2007 | US7211399 Method for detecting leptin receptor ligands |
| 05/01/2007 | US7211398 Human genes and gene expression products: II |
| 05/01/2007 | US7211395 Serum albumin conjugate for use in the transfer and delivery of therapeutic agent to target |
| 05/01/2007 | US7211393 Method to protect DNA ends |
| 05/01/2007 | US7211389 Method for producing immunoglobulins containing protection proteins and their use |
| 05/01/2007 | US7211379 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 05/01/2007 | US7211378 Promoter linked to DNA segment, which upon being transcribed yields a RNA which is capable of being packaged into virions or replicated in the presence of proteins; lipid encapsulation |
| 05/01/2007 | US7211375 Methods for identifying compounds which modulate the activity of MSH5 |
| 05/01/2007 | US7211265 Vaccination modalities |
| 05/01/2007 | US7211264 Salmonella pathogenicity island two (Spi2) double mutant for use as tool in developing vaccine for treatment and prevention of microorganismal and viral infcetions |
| 05/01/2007 | US7211263 Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella |
| 05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
| 05/01/2007 | US7211259 4-1BB polypeptides and DNA encoding 4-1BB polypeptides |
| 05/01/2007 | US7211256 Administering to mammal polyclonal or monoclonal antibody, wherein polyclonal or monoclonal antibody recognizes an epitope of a protein of 48,000 daltons determined by immunoblot, wherein protein is a surface protein of a merozoite of Plasmodium falciparum |
| 05/01/2007 | US7211255 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
| 05/01/2007 | US7211253 Erythropoietin forms with improved properties |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | US7211251 Antibodies to transferrin receptor-like proteins |
| 05/01/2007 | US7211246 Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand) |
| 05/01/2007 | US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand |
| 05/01/2007 | US7211192 Hybrid organic-inorganic adsorbents |
| 05/01/2007 | CA2408224C Cold stress-responsive crtintp gene and use thereof |
| 05/01/2007 | CA2391384C Bt toxin receptors from lepidopteran insects and methods of use |
| 05/01/2007 | CA2200846C Promoter for the receptor tyrosine kinase, tie |
| 05/01/2007 | CA2197160C Platenolide synthase gene |
| 05/01/2007 | CA2192813C Methods of inducing gene expression by ionizing radiation |
| 05/01/2007 | CA2192215C Recombinant aav genome encoding immunodeficiency virus protein |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2174116C Use of .alpha.-1,4-glucan lyase for preparation of 1,5-d-anhydrofructose |
| 05/01/2007 | CA2121497C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 05/01/2007 | CA2120303C Cyclic adhesion inhibitors |
| 05/01/2007 | CA2097286C Control of plant cell proliferation and growth |
| 05/01/2007 | CA2086832C Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
| 05/01/2007 | CA2081704C Biosynthetic process for the preparation of lantibiotics |
| 04/26/2007 | WO2007048103A2 Pkd ligands and polynucleotides encoding pkd ligands |
| 04/26/2007 | WO2007048102A2 Angio-inhibitory peptides derived from human timp-2 |
| 04/26/2007 | WO2007048037A2 METHODS FOR GENERATING MONOVALENT IgG |
| 04/26/2007 | WO2007047997A2 Methods for reducing the mitogenicity of lectin compositions |
| 04/26/2007 | WO2007047988A2 Chimeric human sweet-umami and umami-sweet taste receptors |
| 04/26/2007 | WO2007047938A2 Influenza viruses able to infect canids, uses thereof |
| 04/26/2007 | WO2007047922A2 Polymer-drug conjugates |
| 04/26/2007 | WO2007047859A2 Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| 04/26/2007 | WO2007047829A2 Novel heterodimeric proteins and uses thereof |
| 04/26/2007 | WO2007047791A2 Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
| 04/26/2007 | WO2007047778A2 Compositions for use in identification of influenza viruses |
| 04/26/2007 | WO2007047763A2 Bcr-abl vaccines and methods of use thereof |
| 04/26/2007 | WO2007047738A1 Il-17c antagonists and methods of using the same |
| 04/26/2007 | WO2007047614A2 Glycosylated probnp |
| 04/26/2007 | WO2007047256A2 Svv-based animal vaccines and uses thereof |